Anti-Feline NGF Therapeutic Antibody (Frunevetmab)

Recombinant monoclonal antibody to NGF. Frunevetmab is a Felinized monoclonal antibody that can be potentially used in the treatment of Feline osteoarthritis (OA). It inhibits the activity of nerve growth factor (NGF), a mediator of pain signaling and nerve growth.
Supplier Creative Biolabs
Product # TAB-025ML
Pricing Inquiry
Host Feline
Target NGF
Species Reactivity Feline
Type IgG1, κ
Applications Used for immunoassay techniques such as: Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Immunofluorescence; Immunoprecipitation; Flow Cytometry; Inhibition
Storage Store at -20°C for long-term storage. Avoid freeze/thaw cycles.
Feedback